Search results for "COVID-19"


 
Results 1 - 10 of about 462 for "COVID-19".
Sort by: Relevance | Newest | Oldest

New COVID-19 vaccine recommendations, data on after-effects of infection

The CDC recommended another COVID-19 booster for older patients and ended five-day isolation guidelines, while studies showed that COVID-19 infection was associated with a small cognitive decline and an increase in risk for autoimmune inflammatory rheumatic diseases.
https://immattersacp.org/weekly/archives/2024/03/05/4.htm
5 Mar 2024

Get with the latest ARDS guideline

Experts tasked with updating guidelines on acute respiratory distress syndrome (ARDS) found a lot of new data to incorporate.
https://immattersacp.org/archives/2024/03/get-with-the-latest-ards-guideline.htm
1 Mar 2024

One-fifth of COVID-19 patients taking nirmatrelvir-ritonavir had viral rebound

A small observational study of ambulatory patients with COVID-19 found that 1.8% of untreated patients tested positive again after testing negative, compared to 20.8% of those who took five days of nirmatrelvir-ritonavir.
https://immattersacp.org/weekly/archives/2023/11/14/4.htm
14 Nov 2023

Support, empathy, system changes vital to battling burnout

It is important to provide support to physicians and learners in the ways they and their patients need it.
https://immattersacp.org/archives/2024/03/support-empathy-system-changes-vital-to-battling-burnout.htm
1 Mar 2024

CDC publishes guidance on testing for flu, COVID-19

Patients presenting with acute respiratory illness should be tested for SARS-CoV-2 with nucleic acid detection or antigen detection assay, as well as flu if the results will change clinical management or infection control decisions, the CDC said.
https://immattersacp.org/weekly/archives/2023/12/19/1.htm
19 Dec 2023

Latest COVID-19 studies show need for repeat rapid testing, targeting of antiviral prescriptions

Viral load of SARS-CoV-2 doesn't peak until the fourth day of symptoms, one study found, while other research only saw an effect of nirmatrelvir/ritonavir on death and hospitalization among those who were moderately or severely immunocompromised, not in other high-risk groups.
https://immattersacp.org/weekly/archives/2023/10/03/2.htm
3 Oct 2023

When to test, isolate, prescribe for outpatient COVID-19

Panelists at ACP and Annals of Internal Medicine's eighth virtual forum on COVID-19 discussed the latest recommendations and treatment options.
https://immattersacp.org/archives/2022/03/when-to-test-isolate-prescribe-for-outpatient-covid-19.htm
1 Mar 2022

CDC recommends COVID-19 booster; ACP updates practice points for outpatient treatment

Everyone ages 6 months and older should get an updated COVID-19 vaccine to protect against a potentially serious outbreak this fall and winter, the CDC said last week.
https://immattersacp.org/weekly/archives/2023/09/19/1.htm
19 Sep 2023

Busting COVID-19 vaccination myths

Misinformation and disinformation campaigns have contributed to the death toll of the COVID-19 pandemic. Internists can effectively counter this and encourage vaccinations.
https://immattersacp.org/archives/2021/11/busting-covid-19-vaccination-myths.htm
1 Nov 2021

Coadministration of zoster vaccine, COVID-19 booster appears safe, effective

An industry trial found that coadministration of an mRNA COVID-19 booster vaccine with a first dose of recombinant zoster vaccine was immunologically noninferior to spacing the shots two weeks apart, with a similar safety and reactogenicity profile.
https://immattersacp.org/weekly/archives/2023/06/27/2.htm
27 Jun 2023

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next